Angus Lauder


Angus graduated from the University of Edinburgh with a BSc(Hons) degree in molecular biology before completing a PhD at the Institute of Cancer Research in London UK followed by post-doctoral research at the MRC Laboratory of Molecular Biology in Cambridge UK. Since leaving academia Angus has built a depth of experience in oncology drug discovery managing drug discovery alliances with major pharma partners such as AstraZeneca and has more than 13 years of commercial business development and deal experience working in the commercial partnership team of Cancer Research UK (CRUK). During this time, Angus has led the completion of a large number of IP licenses, spin-out company deals and negotiated some of the highest value drug discovery collaborations undertaken by CRUK Commercial Partnerships including the recently announced partnership with Celgene.